Literature DB >> 18958405

Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina.

Hyuncheol Kim1, Shaun B Robinson, Karl G Csaky.   

Abstract

PURPOSE: To investigate the movement of intravitreally injected human serum albumin nanoparticles (HSA-NP) with respect to nanoparticle surface charge and retinal injury.
METHODS: HSA-NPs were developed by a desolvation technique. HSA-NPs were cationized by covalent coupling of hexamethylenediamine on the particle surface. Either anionic or cationic HSA-NPs were injected to determine the effect of surface charge on intravitreal nanoparticle movement. HSA-NPs were injected intravitreally into both normal and laser photocoagulated eyes to examine the effect of the integrity of retinal tissue on the retinal penetration. The retinal penetration of fluorescence labeled anionic HSA-NPs was investigated by confocal microscopy.
RESULTS: Anionic particles (-33.3+/-6.1 mV) more easily diffused through the 3-dimensional vitreal network of collagen fibrils than did their cationic counterparts (11.7+/-7.2 mV). In the laser photocoagulated retina, more HSA-NPs were detected in the choroidal space, compared to the normal retina. The immunohistochemical studies indicated that HSA-NPs were taken up into Müller cells.
CONCLUSIONS: The movement of intravitreal nanoparticles depended on both nanoparticles surface charge and retinal injury. The Müller cells might play an important role in the retinal penetration of nanoparticles. The anionic HSA-NP is a promising drug or gene delivery carrier to the sub-retinal space and RPE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18958405     DOI: 10.1007/s11095-008-9745-6

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  34 in total

Review 1.  Drug delivery for posterior segment eye disease.

Authors:  D H Geroski; H F Edelhauser
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-04       Impact factor: 4.799

Review 2.  Nanomedicines for overcoming biological barriers.

Authors:  Maria José Alonso
Journal:  Biomed Pharmacother       Date:  2004-04       Impact factor: 6.529

3.  Distribution of glycoconjugates in the human retinal internal limiting membrane.

Authors:  S R Russell; J D Shepherd; G S Hageman
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-06       Impact factor: 4.799

4.  A study of the ability of tissue plasminogen activator to diffuse into the subretinal space after intravitreal injection in rabbits.

Authors:  M Kamei; K Misono; H Lewis
Journal:  Am J Ophthalmol       Date:  1999-12       Impact factor: 5.258

5.  Potential of albumin nanoparticles as carriers for interferon gamma.

Authors:  Sara Segura; Socorro Espuelas; María Jesús Renedo; Juan Manuel Irache
Journal:  Drug Dev Ind Pharm       Date:  2005-03       Impact factor: 3.225

6.  Distribution of heparan sulfate proteoglycans in embryonic chicken neural retina and isolated inner limiting membrane.

Authors:  L Chai; J E Morris
Journal:  Curr Eye Res       Date:  1994-09       Impact factor: 2.424

7.  Effect of particle size of polymeric nanospheres on intravitreal kinetics.

Authors:  E Sakurai; H Ozeki; N Kunou; Y Ogura
Journal:  Ophthalmic Res       Date:  2001 Jan-Feb       Impact factor: 2.892

8.  Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies.

Authors:  M Ruponen; S Ylä-Herttuala; A Urtti
Journal:  Biochim Biophys Acta       Date:  1999-01-08

9.  Factor VII related antigen as an endothelial cell marker in benign and malignant diseases.

Authors:  M Sehested; K Hou-Jensen
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

10.  Intravitreal injection of triamcinolone for diffuse diabetic macular edema.

Authors:  Jost B Jonas; Ingrid Kreissig; Antje Söfker; Robert F Degenring
Journal:  Arch Ophthalmol       Date:  2003-01
View more
  36 in total

Review 1.  Ocular drug delivery.

Authors:  Ripal Gaudana; Hari Krishna Ananthula; Ashwin Parenky; Ashim K Mitra
Journal:  AAPS J       Date:  2010-05-01       Impact factor: 4.009

2.  Diffusion Regulation in the Vitreous Humor.

Authors:  Benjamin Tillmann Käsdorf; Fabienna Arends; Oliver Lieleg
Journal:  Biophys J       Date:  2015-11-17       Impact factor: 4.033

Review 3.  AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects.

Authors:  Zongchao Han; Shannon M Conley; Muna I Naash
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-10       Impact factor: 4.799

Review 4.  Challenges and opportunities for drug delivery to the posterior of the eye.

Authors:  Fernando J Cabrera; Daniel C Wang; Kartik Reddy; Ghanashyam Acharya; Crystal S Shin
Journal:  Drug Discov Today       Date:  2019-06-05       Impact factor: 7.851

Review 5.  Drug and gene delivery to the back of the eye: from bench to bedside.

Authors:  Cheryl L Rowe-Rendleman; Shelley A Durazo; Uday B Kompella; Kay D Rittenhouse; Adriana Di Polo; Alan L Weiner; Hans E Grossniklaus; Muna I Naash; Alfred S Lewin; Alan Horsager; Henry F Edelhauser
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-28       Impact factor: 4.799

6.  Dendrimers for Ocular Drug Delivery.

Authors:  Michael G Lancina; Hu Yang
Journal:  Can J Chem       Date:  2017-05-11       Impact factor: 1.118

Review 7.  Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

Authors:  Rahel Zulliger; Shannon M Conley; Muna I Naash
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

8.  Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogs.

Authors:  R F Boyd; D G Sledge; S L Boye; S E Boye; W W Hauswirth; A M Komáromy; S M Petersen-Jones; J T Bartoe
Journal:  Gene Ther       Date:  2015-10-15       Impact factor: 5.250

Review 9.  Ocular delivery of proteins and peptides: Challenges and novel formulation approaches.

Authors:  Abhirup Mandal; Dhananjay Pal; Vibhuti Agrahari; Hoang My Trinh; Mary Joseph; Ashim K Mitra
Journal:  Adv Drug Deliv Rev       Date:  2018-01-13       Impact factor: 15.470

Review 10.  Nanoparticle-motivated gene delivery for ophthalmic application.

Authors:  Rajendra Narayan Mitra; Min Zheng; Zongchao Han
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.